S-100B as Pre-Head CT Scan Screening Test After Mild Traumatic Brain Injury
NCT ID: NCT00717301
Last Updated: 2015-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1252 participants
OBSERVATIONAL
2008-09-30
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnostic Performance of the S100B Protein in the Prognosis of Patients With Mild Head Trauma With Risk of Complications in Patients Over 65 Years Old.
NCT05091125
Interest of the S100B Protein Assay in Mild Traumatic Brain Injuries at the DOUAI Hospital
NCT05285774
S100 Protein in Minor/Mild Traumatic Brain Injury
NCT00822445
Medico-economic Interest of the Protein S100b in Mild Head Trauma Under Anti-thrombotics
NCT04305821
Field Triage of Older Adults Who Experience Traumatic Brain Injury
NCT01884103
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Head Trauma
Patients presenting to any of the AHCC/ERNES Emergency Departments with head trauma.
No interventions assigned to this group
Control subjects
Patients presenting to the Univ of Rochester Medical Center/Strong Memorial Hospital Outpatient Laboratory for routine blood draw.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of mild TBI per study definition
* Arrival at the ED within 4 hours of injury
* ED workup includes a Head CT
(Controls are eligible if they present to the Outpatient Lab for routine bloodwork during enrollment hours)
Exclusion Criteria
* Head CT not done as part of clinical emergency care
* Incarcerated
* Non-English or Spanish speakers
* Absence of parent/guardian for minor subjects
* Subject and/or parent/guardian do not have capacity to consent
* Head injury due to birth trauma, anoxia, inflammatory, toxic, infectious or metabolic encephalopathies that are not complications of head trauma
* Ischemic or hemorrhagic stroke without associated trauma
(Controls are excluded if they have any of the following:History of brain tumor, melanoma and/or Alzheimer's disease; History of concussion, bone fracture or stroke (CVA or TIA) in the past month; History of surgery in the past month; Inability to obtain consent from subject and/or parent due to lack of capacity or absence of parent/guardian of minor; Inability to speak or read English; Incarceration)
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Academic Health Center Consortium (not Univ of Minnesota)
UNKNOWN
New York State Department of Health
OTHER_GOV
Emergency Research Network of the Empire State
UNKNOWN
University of Rochester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jeffrey Bazarian
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeffrey J Bazarian, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Rochester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Albany Medical College
Albany, New York, United States
Erie County Medical Center
Buffalo, New York, United States
Bassett Healthcare
Cooperstown, New York, United States
University of Rochester Medical Center
Rochester, New York, United States
SUNY Upstate Medical Center at Syracuse
Syracuse, New York, United States
Guthrie
Sayre, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C806001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.